BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28611048)

  • 1. Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells.
    Rohira AD; Yan F; Wang L; Wang J; Zhou S; Lu A; Yu Y; Xu J; Lonard DM; O'Malley BW
    Cancer Res; 2017 Aug; 77(16):4293-4304. PubMed ID: 28611048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1.
    Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; O'Malley BW
    Mol Endocrinol; 2011 Dec; 25(12):2041-53. PubMed ID: 22053001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1.
    Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; Wang J; Qi R; Matzuk AJ; Song X; Madoux F; Hodder P; Chase P; Griffin PR; Zhou S; Liao L; Xu J; O'Malley BW
    Cancer Res; 2014 Mar; 74(5):1506-1517. PubMed ID: 24390736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.
    Wang L; Yu Y; Chow DC; Yan F; Hsu CC; Stossi F; Mancini MA; Palzkill T; Liao L; Zhou S; Xu J; Lonard DM; O'Malley BW
    Cancer Cell; 2015 Aug; 28(2):240-52. PubMed ID: 26267537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.
    Eedunuri VK; Rajapakshe K; Fiskus W; Geng C; Chew SA; Foley C; Shah SS; Shou J; Mohamed JS; Coarfa C; O'Malley BW; Mitsiades N
    Mol Endocrinol; 2015 Aug; 29(8):1170-83. PubMed ID: 26066330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.
    Rohira AD; Lonard DM
    Biochem Pharmacol; 2017 Sep; 140():1-7. PubMed ID: 28390937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An acetylation-enhanced interaction between transcription factor Sox2 and the steroid receptor coactivators facilitates Sox2 transcriptional activity and function.
    Huang Y; Duan X; Wang Z; Sun Y; Guan Q; Kang L; Zhang Q; Fang L; Li J; Wong J
    J Biol Chem; 2021 Dec; 297(6):101389. PubMed ID: 34762910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer.
    Lee WK; Kim WG; Fozzatti L; Park S; Zhao L; Willingham MC; Lonard D; O'Malley BW; Cheng SY
    Endocr Relat Cancer; 2020 Apr; 27(4):209-220. PubMed ID: 31977311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of verrucarin a as a potent and selective steroid receptor coactivator-3 small molecule inhibitor.
    Yan F; Yu Y; Chow DC; Palzkill T; Madoux F; Hodder P; Chase P; Griffin PR; O'Malley BW; Lonard DM
    PLoS One; 2014; 9(4):e95243. PubMed ID: 24743578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression.
    Bhummaphan N; Petpiroon N; Prakhongcheep O; Sritularak B; Chanvorachote P
    Phytomedicine; 2019 Sep; 62():152932. PubMed ID: 31100681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of improved SRC-3 inhibitors as breast cancer therapeutic agents.
    Qin L; Chen J; Lu D; Jain P; Yu Y; Cardenas D; Peng X; Yu X; Xu J; Wang J; O'Malley BW; Lonard DM
    Endocr Relat Cancer; 2021 Aug; 28(10):657-670. PubMed ID: 34310341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3.
    Song X; Chen J; Zhao M; Zhang C; Yu Y; Lonard DM; Chow DC; Palzkill T; Xu J; O'Malley BW; Wang J
    Proc Natl Acad Sci U S A; 2016 May; 113(18):4970-5. PubMed ID: 27084884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma.
    Song X; Chen H; Zhang C; Yu Y; Chen Z; Liang H; Van Buren G; McElhany AL; Fisher WE; Lonard DM; O'Malley BW; Wang J
    Cancer Lett; 2019 Feb; 442():310-319. PubMed ID: 30423406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell.
    Nishi M; Akutsu H; Kudoh A; Kimura H; Yamamoto N; Umezawa A; Lee SW; Ryo A
    Oncotarget; 2014 Sep; 5(18):8665-80. PubMed ID: 25228591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
    Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
    Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
    Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
    Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.
    Karmakar S; Foster EA; Smith CL
    Endocrinology; 2009 Apr; 150(4):1588-96. PubMed ID: 19095746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
    Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
    Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockout of SRC-1 and SRC-3 in Mice Decreases Cardiomyocyte Proliferation and Causes a Noncompaction Cardiomyopathy Phenotype.
    Chen X; Qin L; Liu Z; Liao L; Martin JF; Xu J
    Int J Biol Sci; 2015; 11(9):1056-72. PubMed ID: 26221073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells.
    Bozickovic O; Skartveit L; Engelsen AST; Helland T; Jonsdottir K; Flågeng MH; Fenne IS; Janssen E; Lorens JB; Bjørkhaug L; Sagen JV; Mellgren G
    J Steroid Biochem Mol Biol; 2019 Jan; 185():57-70. PubMed ID: 30048685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.